Biogen Inc. is a leading American biotechnology company headquartered in Cambridge, Massachusetts, focused on discovering, developing, and delivering innovative therapies for neurological diseases. With a strong pipeline of highly specialized products, Biogen addresses critical conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy. The company is committed to advancing scientific research and improving patient outcomes through its robust portfolio and collaborations with healthcare stakeholders worldwide. Biogen's dedication to innovation and patient care positions it as a prominent player in the biotechnology sector.

NASDAQ

USA

HEALTHCARE

DRUG MANUFACTURERS - GENERAL

225 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142

December

$23.4 Billion

$3.22 Billion

15.3

10.45

$0.00

0.0%

0.125